Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by MaiwaldChristian Meyer of Maiwald looks at the ineffective enforcement of a preliminary injunction in a German case concerning the requirements for a bank guarantee as security -
Sponsored by Satyapon & PartnersSatyapon & PartnersのKritsana MingtongkhumとShantanu Ajit Tambeが、マドリッドプロトコル・ルートでタイに新規商標出願する場合と直接出願する場合を比較し、そのメリットとデメリットについて解説します
-
Sponsored by FirstLaw PC増加するデジタルヘルスケア及びバイオマーカー分野の特許出願に韓国特許庁はどのように対応し審査実務を行っているのだろうか。韓国・第一特許法人の孫世靖(ソンセジョン)弁理士が詳しく解説する。
-
Sponsored by Satyapon & PartnersKritsana Mingtongkhum and Shantanu Ajit Tambe of Satyapon & Partners discuss the pros and cons of filing new trademark applications in Thailand via Madrid compared to direct filings
-
Sponsored by FirstLaw PCSe Jeong Son of FirstLaw PC explains how the Korean Intellectual Property Office has reacted to the significant increase in patent applications across the fields of digital healthcare and biomarkers
-
Sponsored by Hechanova GroupHechanova & CoのEditha R Hechanova, Brenda P RiveraそしてChrissie Ann L Barredoが、フィリピンにおける意匠出願と保護に関するよくある質問について考察します
